Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match

Transplant Proc. 2002 Aug;34(5):1614-6. doi: 10.1016/s0041-1345(02)03044-0.

Authors

C J Sonnenday¹, L E Ratner, A A Zachary, J F Burdick, M D Samaniego, E Kraus, D S Warren, R A Montgomery

Affiliation

¹ Department of Surgery, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA.

PMID: 12176507
DOI: 10.1016/s0041-1345(02)03044-0

No abstract available

MeSH terms

Adult
Aged
Combined Modality Therapy
Creatinine / blood
Female
Follow-Up Studies
Histocompatibility Testing*
Humans
Immunoglobulins, Intravenous / therapeutic use*
Isoantibodies / blood
Kidney Transplantation / immunology
Kidney Transplantation / physiology*
Living Donors*
Male
Middle Aged
Plasmapheresis*
Racial Groups
Retrospective Studies
Tacrolimus / therapeutic use
Time Factors
United States

Substances

Immunoglobulins, Intravenous
Isoantibodies
Creatinine
Tacrolimus